
DHR-PA
Healthcare · Diagnostics & Research · $169.33B market cap
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 4 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| May 6, 2020 | After the close | 1.01 | 1.05 | +4.0% |
| Jan 30, 2020 | Before the open | 1.25 | 1.28 | +2.4% |
| Oct 24, 2019 | Before the open | 1.15 | 1.16 | +0.9% |
| Jul 18, 2019 | Before the open | 1.16 | 1.19 | +2.6% |
| Apr 18, 2019 | Before the open | 1.01 | 1.07 | +5.9% |
| Jan 29, 2019 | Before the open | 1.27 | 1.28 | +0.8% |
| Oct 18, 2018 | Before the open | 1.08 | 1.10 | +1.9% |
| Jul 19, 2018 | Before the open | 1.09 | 1.15 | +5.5% |
| Apr 19, 2018 | Before the open | 0.94 | 0.99 | +5.3% |
| Jan 30, 2018 | Before the open | 1.16 | 1.19 | +2.6% |
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes;…